Aug 19, 2011 - 6:08 pm
My fiancé was diagnosed with stage 3c ovca in Feb 2011. She under went chemo to reduced size and spread of the tumor before surgery. She had debulking surgery in April 2011. dr was able to remove all visible cancer but did say that her spread was “extensive” she had complete hysterectomy, her appendix removed, and part of her colon and rectum removed. Before surgery her CA125 was 15,000 and it was reduced to around 200 after. She started chemo again post surgery with taxol/cisplantin. Unfortunately after three rounds her ca125 has increased to over 500 and a CT scan shows recurring cancer in several places on liver, and also in her abdomen and pelvis. The plan was to switch to Doxil and avasten, but due to the shortage of doxil she will use topotecan/avasten instead. Can anyone tell us what to expect in regards to her cancer responding? It seems as though recurring during first line treatment is “worst case scenario.” Does any one have a similar story? We just want to know what to expect, whether it is good or bad.